Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvey Nash Group Regulatory News (HVN)

  • There is currently no data for HVN

Director/PDMR Shareholding

29 Oct 2018 07:00

RNS Number : 3880F
Harvey Nash Group PLC
29 October 2018
 

29 October 2018

 

Director/PDMR Shareholding

Harvey Nash Group Plc

("the Company")

Notification of Transaction by Directors

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, the Company was advised on 26 October 2018 that Albert Ellis, Simon Wassall and Mark Garratt had acquired ordinary shares in London on 26 October 2018 at a price of £0.05 per ordinary share as a result of the exercise of options granted under the Company's Performance Share Plan which became exercisable as a result of the offer by The Power of Talent Ltd being declared wholly unconditional on 26 October 2018:

Director

Number of shares purchased

Price per share

Resulting holding

Albert Ellis

1,385,499

£0.05

2,267,084*

Simon Wassall

930,215

£0.05

1,259,331

Mark Garratt

381,229

£0.05

416,787

*Includes 658,923 ordinary shares held by family members.

The notification below provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 

1

Details of the person discharging managerial responsibility

a)

Name

Albert Ellis

2

Reason for the notification

a)

Position/status

Chief Executive

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

1,385,499

£69,274.95

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Simon Wassall

2

Reason for the notification

a)

Position/status

European Managing Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

930,215

£46,510.75

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Mark Garratt

2

Reason for the notification

a)

Position/status

Group Finance Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

381,229

£19,061.45

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

Contact:

Mark Garratt, Group Finance Director - 020 7333 0033

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFEUFMMFASEES
Date   Source Headline
2nd Jul 20127:00 amRNSTotal Voting Rights
29th Jun 201211:37 amRNSDirector/PDMR Shareholding
28th Jun 201212:35 pmRNSHarvey Nash Banking Survey
28th Jun 201211:24 amRNSResult of AGM
12th Jun 20127:00 amRNSBlocklisting Interim Review
11th Jun 20127:00 amRNSChange of Registered Office
6th Jun 20124:27 pmRNSAnnual Information Update
6th Jun 20124:25 pmRNSDirector/PDMR Shareholding
1st Jun 20126:00 pmRNSNotice of AGM
1st Jun 201212:06 pmRNSDirector/PDMR Shareholding
1st Jun 201210:38 amRNSDirector/PDMR Shareholding
1st Jun 20127:00 amRNSInterim Management Statement
1st Jun 20127:00 amRNSTotal Voting Rights
31st May 201210:04 amRNSDirector/PDMR Shareholding
16th May 20124:27 pmRNSHolding(s) in Company
14th May 20129:00 amRNSCIO Survey
1st May 20127:00 amRNSTotal Voting Rights
30th Apr 20128:48 amRNSDirector/PDMR Shareholding
30th Apr 20127:00 amRNSFinal Results
4th Apr 20123:22 pmRNSSenior Independent Director
2nd Apr 20127:00 amRNSTotal Voting Rights
29th Mar 20122:06 pmRNSDirector/PDMR Shareholding
28th Mar 20129:51 amRNSDirector/PDMR Shareholding
1st Mar 201212:26 pmRNSDirector/PDMR Shareholding
1st Mar 20127:00 amRNSTotal Voting Rights
29th Feb 20123:26 pmRNSHolding(s) in Company
28th Feb 20124:35 pmRNSPrice Monitoring Extension
17th Feb 20127:03 amRNSHarvey Nash Invests in London's Future
17th Feb 20127:00 amRNSTrading Statement
16th Feb 201212:29 pmRNSHolding(s) in Company
16th Feb 201210:39 amRNSHolding(s) in Company
15th Feb 201212:42 pmRNSHolding(s) in Company
9th Feb 20124:40 pmRNSSecond Price Monitoring Extn
9th Feb 20124:35 pmRNSPrice Monitoring Extension
7th Feb 20124:40 pmRNSSecond Price Monitoring Extn
7th Feb 20124:35 pmRNSPrice Monitoring Extension
1st Feb 20127:00 amRNSTotal Voting Rights
30th Jan 201211:06 amRNSDirector/PDMR Shareholding
3rd Jan 20127:00 amRNSTotal Voting Rights
28th Dec 20117:00 amRNSDirector/PDMR Shareholding
13th Dec 201111:44 amRNSDirector/PDMR Shareholding
12th Dec 20117:00 amRNSBlocklisting Interim Review
1st Dec 20117:00 amRNSTotal Voting Rights
29th Nov 20114:16 pmRNSDirector/PDMR Shareholding
25th Nov 20117:00 amRNSInterim Management Statement
18th Nov 20119:23 amRNSDirector/PDMR Shareholding
1st Nov 20117:00 amRNSTotal Voting Rights
28th Oct 201111:36 amRNSDirector/PDMR Shareholding
13th Oct 201111:39 amRNSDirector/PDMR Shareholding
7th Oct 20119:14 amRNSEBT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.